Drug survival of apremilast in patients treated for psoriasis in a real-world setting

被引:19
|
作者
Lee, Erica B. [1 ]
Amin, Mina [2 ,4 ]
Wu, Jashin J. [3 ]
机构
[1] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA
[2] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA
[3] Kaiser Permanente Los Angeles, Dept Dermatol, Med Ctr, 1515 North Vermont Ave,5th Floor, Los Angeles, CA 90027 USA
[4] Kaiser Permanente Los Angeles, Dept Med, Med Ctr, Los Angeles, CA USA
关键词
ORAL PHOSPHODIESTERASE-4 INHIBITOR; SEVERE PLAQUE PSORIASIS; CONTROLLED-TRIAL; PHASE-III; EFFICACY; MODERATE; SAFETY;
D O I
10.1016/j.jaad.2018.03.028
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:760 / 761
页数:3
相关论文
共 50 条
  • [31] Comment on "Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study''
    Palacios-Garcia, Laura
    Gomez-de Castro, Celia
    Mir-Bonafe, Marc
    Calzon, Cristina
    Galache, Cristina
    Santos-Juanes, Jorge
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : E81 - E82
  • [32] Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis
    Elgaard, Cathrine Dawn Buttner
    Iversen, Lars
    Hjuler, Kasper Fjellhaugen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [33] Drug survival of guselkumab for psoriasis in a real-world setting: a single-center retrospective chart review
    Lee, Erica B.
    Reynolds, Kelly A.
    Pithadia, Deeti J.
    Egeberg, Alexander
    Wu, Jashin J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (04) : 342 - 343
  • [34] Real-world efficacy of apremilast in patients with moderate plaque psoriasis: Results from the Corrona Psoriasis Registry
    Merola, Joseph
    Gottlieb, Alice B.
    McLean, Robert R.
    Cirulli, Joshua
    Williams, Catherine
    Linowski, Gregory
    Litman, Heather J.
    Guo, Ning
    Emeanuru, Kelechi
    Strober, Bruce
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB115 - AB115
  • [35] DRUG SURVIVAL OF SECUKINUMAB FOR PSORIATIC ARTHRITIS IN A REAL-WORLD SETTING
    Valero, Marta
    Joven-Ibanez, Beatriz
    Martin, Maria
    Campos Esteban, Jose
    Merino Argumanez, Carolina
    Emperiale, Valentina
    Perez Gomez, Ana
    Bachiller-Corral, Javier
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1862 - 1862
  • [36] Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting
    Fougerousse, A. -C.
    Maccari, F.
    Beauchet, A.
    Parier, J.
    Boulard, C.
    Becherel, P. -A.
    Quiles-Tsimaratos, N.
    Le Guyadec, T.
    Thomas-Beaulieu, D.
    Halioua, B.
    Begon, E.
    Bastien, M.
    Perrot, J. -L.
    Pallure, V.
    Bilan, P.
    Steff, M.
    Pfister, P.
    Vermersch-Langlin, A.
    Boye, T.
    Mery-Bossard, L.
    Maillard, H.
    Kemula, M.
    Girard, C.
    Poiraud, C.
    Monfort, J. -B.
    Kupfer-Bessaguet, I.
    Perrussel, M.
    Lons-Danic, D.
    Sultan, N.
    Lorier, E.
    Zeitoun, M.
    Wagner, L.
    Gabison, G.
    Mahe, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (12) : E476 - E478
  • [37] Diabetes Burden and Effects of Apremilast on Changes in Cardiometabolic Parameters in Patients with Psoriasis (PsO) or Psoriatic Arthritis (PsA) in a Real-World Setting
    Orroth, Kate
    Cavanaugh, Cristi
    Qian, Xi
    Kumparatana, Pam
    Klyachkin, Yuri
    Colgan, Stephen
    Cordey, Myriam
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2334 - 2337
  • [38] Real-world treatment patterns of adults with psoriasis initiated on apremilast or biologics
    Wu, Jashin J.
    Wang, Ann
    Jobson, Greeta
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
  • [39] Reply to: "Comment on 'Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study'''
    Chiricozzi, Andrea
    Torres, Tiago
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : E83 - E83
  • [40] Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
    Megna, Matteo
    Patruno, Cataldo
    Bongiorno, Maria Rita
    Gambardella, Alessio
    Guarneri, Claudio
    Foti, Caterina
    Lembo, Serena
    Loconsole, Francesco
    Fabbrocini, Gabriella
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2629 - 2633